Fake drugs dealer gets 13 years prison in USA

6 November 2006

A Florida, USA counterfeit drug trafficker has been sentenced to nearly 14 years in prison and forfeited millions of dollars as part of a plea bargain with the US Attorney General's office. Julio Cesar Cruz, from Miami, was described by prosecutors as being part of a conspiracy to sell "counterfeit, misbranded and illegally imported drugs" between February 2002 and April 2003.

Among the drugs was global drug giant Pfizer's blockbuster statin Lipitor (atorvastatin). The US Food and Drug Administration told journalists that there were no reports of ill effects from the counterfeit drugs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight